What is Eli Lilly's other non-current assets?

Eli Lilly (LLY) reported other non-current assets of $7.23B in Q1 2026.

How has Eli Lilly's other non-current assets changed year-over-year?

Eli Lilly's other non-current assets increased by 19.0% year-over-year, from $6.07B to $7.23B.

What is the long-term trend for Eli Lilly's other non-current assets?

Over 5 years (2020 to 2025), Eli Lilly's other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.

Eli Lilly LLY Other Non-Current Assets

Other Non-Current Assets at other companies

Cardinal HealthCAH

$2B+25.1%

Johnson & JohnsonJNJ

——

PfizerPFE

——

AmgenAMGN

——

Ionis PharmaceuticalsIONS

——

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

See full

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

See full

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

See full

Market cap$979.64B+10.8%

Enterprise value$1.02T+10.6%

P/E38.8×-40.9×

P/S13.6×-4.5×

Profitability

See full

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

See full

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eli Lilly's other non-current assets?: Eli Lilly (LLY) reported other non-current assets of $7.23B in Q1 2026.
How has Eli Lilly's other non-current assets changed year-over-year?: Eli Lilly's other non-current assets increased by 19.0% year-over-year, from $6.07B to $7.23B.
What is the long-term trend for Eli Lilly's other non-current assets?: Over 5 years (2020 to 2025), Eli Lilly's other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.